Atlas Trials

Stage IVA Rectal Cancer AJCC v8

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IVA Rectal Cancer AJCC v8

RecordFirmDate
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)M.D. Anderson Cancer Center2021-05-12
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer (NCT04616183)M.D. Anderson Cancer Center2020-12-02
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial (NCT04599140)M.D. Anderson Cancer Center2020-10-14
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer (NCT04362839)City of Hope Medical Center2020-05-27
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer (NCT03992456)Academic and Community Cancer Research United2020-04-24
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial (NCT03765736)Academic and Community Cancer Research United2020-04-20
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924)Roswell Park Cancer Institute2019-12-27
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer (NCT03592641)National Cancer Institute (NCI)2019-07-25
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer (NCT02107105)M.D. Anderson Cancer Center2014-05-16
Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer (NCT02874885)M.D. Anderson Cancer Center2013-09-05

Track Stage IVA Rectal Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.